Skip to main content
Premium Trial:

Request an Annual Quote

Karen Kelly, John Whitehead, Michael Falk, Emily Bauer, Janet Kelly, Craig Heim, Mark Stoveken, Michael Dunham

CU Clinical Thoracic Oncology Director Named KU Cancer Center’s New Deputy Director KU Cancer Center’s New Deputy Director

Karen Kelly
Karen Kelly has been named deputy director of the University of Kansas Cancer Center in Kansas City, Kan., and one of three Frank B. Tyler chairs in cancer research, effective Oct. 2. In her new position, KU Cancer Center said Kelly will play a key role in helping it achieve the Comprehensive Cancer Center designation from the National Cancer Institute, a designation held by 39 US institutions.
KU also said Kelly plans to develop a “comprehensive” lung cancer program as well as a “wide-ranging” cancer clinical and research program, plus expand patient involvement in clinical trials.
Kelly most recently served as director of the clinical thoracic oncology program and professor of medical oncology at the University of Colorado Cancer Center.
A native of Derby, Kan., Kelly received her medical degree from KU and completed her residency and fellowship at CU's Health Sciences Center.

Ex-Lower Manhattan Development Chair Joins AMDeC As Co-Chairman
John Whitehead has been unanimously voted an honorary member and co-chairman of the AMDeC Foundation. Whitehead will chair the foundation with Maurice (Hank) Greenberg, who has chaired the board since 1998.
AMDeC is a consortium of 30 medical schools, academic health centers, and medical science research organizations in New York state.
“I intend to work on diversifying funding sources and exploring new opportunities to further AMDeC’s initiatives,” Whitehead said in an Oct. 4 press release announcing his appointment.
Whitehead is currently chairman emeritus of the Brookings Institution and the Asia Society, and previously chaired the Lower Manhattan Development Corporation, a state entity created to oversee redevelopment of the World Trade Center site after the Sept. 11, 2001, attacks. He spent 37 years at Goldman Sachs, rising to partner in 1956 and co-chairman and senior partner in 1976 before retiring in 1984. The following year, he was appointed deputy secretary of state under George Shultz, and later received the Presidential Citizens’ Medal from President Ronald Reagan. 

Wisconsin Alumni Research Foundation Announces Three New Hires, Two Promotions
The Wisconsin Alumni Research Foundation has promoted two executives and hired three new staffers, including two who will fill newly created positions:
Michael Falk has been promoted to general counsel, supervising the professionals who oversee WARF's patent program and manage its legal affairs, including the foundation’s intellectual property team, which he has led for the past four years. The IP team identifies and promotes new technologies developed from research conducted on the University of Wisconsin-Madison campus.
Falk holds a bachelor's degree from Columbia University; as well as a law degree, a master's degree in business administration, and a master's degree in bacteriology, all from UW-Madison.
Emily Bauer has been promoted to licensing manager for agricultural biotechnology, succeeding Brad Ricker, who recently left WARF to join UW-Madison's Office of Corporate Relations.
Bauer will work closely with UW-Madison's College of Agricultural and Life Sciences and industry partners to promote the commercialization of new technologies. She holds a bachelor's degree in agricultural journalism from UW-Madison, as well as master's degrees in technical communication from the University of Washington and biotechnology from UW-Madison.
Janet Kelly has been hired as communications director for WARF and the technology transfer organization's affiliates, WiCell, WiSys and the Morgridge Institute for Research. In this newly created position, Kelly will develop strategic communications plans for each entity. In addition, she will direct media relations, external communications and event planning. Kelly will work closely with Andrew Cohn, who directs WARF's government and associations relations and has worked at the foundation for the past seven years.
Kelly holds a BA degree in English from the University of Illinois at Urbana-Champaign and has completed the executive education program for manger development at Duke University's Fuqua School of Business.
Craig Heim has been named the WARF licensing manager for start-up companies. In this newly created position, Heim will help launch nascent Madison-area businesses that have licensed UW-Madison technologies through WARF. The foundation said its creation of Heim’s position reflected a renewed commitment to encouraging economic development in Madison and
Dane County.
He holds a UW-Madison BSc degree in chemical engineering, as well as an MBA from the Weinert Applied Ventures in Entrepreneurship program.
Mark Stoveken has been hired as a pharmaceutical licensing associate focusing on bone health and the development and commercialization of pharmaceutical uses of Vitamin D. The discovery of Vitamin D led to WARF's founding in 1925.
Stoveken, who holds a bachelor's degree in international business and economics from UW-
Madison. In his new position, Stoveken will collaborate with the namesake of Hectorol, Hector DeLuca, one of WARF's most prolific inventors.
WARF announced the promotions and new appointments on Oct. 1.

Chairman of WorkWise, Intercim Joins BioForce Nanosciences Holdings Board
Michael Dunham, the chairman and owner of WorkWise and Intercim, two companies specializing in software systems for manufacturers, has been named to the board of directors of BioForce Nanosciences Holdings, an Ames, Iowa, company focused on developing and commercializing nanotech tools and solutions for the life sciences.
Previously Dunham was senior vice president-business development for Industrial & Financial Systems, a co-founder and CEO of public software company Effective Management Systems, and a director for the nanotechnology company Arryx Technology.

File Attachments
The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.